Billionaire Profile
Liu Gexin & family
Global Rank
#2311

Image: Unsplash Contributor | Unsplash License | via Unsplash

Liu Gexin & family

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$1.698B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+9.11% (24h)
Age
74
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Liu Gexin, a prominent figure in the Chinese pharmaceutical industry, chairs Sichuan Kelun Pharmaceutical. His career began in 1996 when he established the Kelun Pharmaceutical Factory, which later became Sichuan Kelun Pharmaceutical. With a net worth of $1.13 billion, as of February 2026, Liu Gexin's wealth stems from his successful ventures in the healthcare sector. He was recognized as a "Top 10 Commercial Leader in China's Pharmaceutical Industry" in 2017. His leadership has driven innovation and social responsibility within the pharmaceutical industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Career

Liu Gexin's career began in 1996 when he set up Kelun Pharmaceutical Factory, the predecessor of Sichuan Kelun Pharmaceutical. His work contributed to the growth of the pharmaceutical industry in China.

Rise to Success

Sichuan Kelun Pharmaceutical went public on the Shenzhen Stock Exchange in 2010. Liu Gexin regained his billionaire status with the rise of Kelun's share price and the growth of pharmaceutical sales in China. His company's revenue increased significantly, contributing to the surge in his net worth.

Key Business Strategies

Liu Gexin's business strategies include expanding product lines and sales networks. Kelun announced in December 2013 to purchase up to 30% of Hong Kong-listed Lijun International Pharmaceutical. He has focused on innovation and assumed social responsibilities while seeking corporate development.

Philanthropy

While specific philanthropy amounts are not available, Liu Gexin is recognized for his contributions and focus on public welfare.

Career Milestones

1996

Founded Kelun Pharmaceutical Factory

Established the predecessor company to Sichuan Kelun Pharmaceutical, marking the start of his venture in the pharmaceutical industry.

2010

Sichuan Kelun Pharmaceutical IPO

The company went public on the Shenzhen Stock Exchange, a key milestone in its growth.

2017

Top 10 Commercial Leader

Recognized as one of the "Top 10 Commercial Leaders in China's Pharmaceutical Industry".

Controversies & Challenges

2025

Forced Labor Allegations

Rep. Cory Mills sent a letter demanding answers regarding ties to the Chinese Communist Party and the use of forced labor in the supply chain.